TBIO Trademark

Trademark Overview

On Monday, November 17, 2014, a trademark application was filed for TBIO with the United States Patent and Trademark Office. The USPTO has given the TBIO trademark a serial number of 86456235. The federal status of this trademark filing is REGISTERED as of Tuesday, November 24, 2020. This trademark is owned by Turnstone Biologics Inc.. The TBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Oncolytic viruses namely, oncolytic vaccines, viral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products for the prevention and treatment of cancer and infectious diseases, namely, biochemicals in the form of monoclonal antibodies for the treatment of cancer and chronic viral infections, biochemicals in the form of monoclonal antibodies for research use, protein and peptides for the treatment of cancer and chronic viral infections, pharmaceuticals and vaccines for human and veterinary use for the treatment of cancer and chronic viral infections

Research and development in connection with oncolytic viruses and oncolytic vaccines, viral vectors, pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases and pharmaceutical and vaccine products in the field of cancer and infectious disease
tbio

General Information

Serial Number86456235
Word MarkTBIO
Filing DateMonday, November 17, 2014
Status700 - REGISTERED
Status DateTuesday, November 24, 2020
Registration Number6202962
Registration DateTuesday, November 24, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesOncolytic viruses namely, oncolytic vaccines, viral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products for the prevention and treatment of cancer and infectious diseases, namely, biochemicals in the form of monoclonal antibodies for the treatment of cancer and chronic viral infections, biochemicals in the form of monoclonal antibodies for research use, protein and peptides for the treatment of cancer and chronic viral infections, pharmaceuticals and vaccines for human and veterinary use for the treatment of cancer and chronic viral infections
Goods and ServicesResearch and development in connection with oncolytic viruses and oncolytic vaccines, viral vectors, pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases and pharmaceutical and vaccine products in the field of cancer and infectious disease
Pseudo MarkTURNSTONE BIOLOGICS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 24, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 24, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTurnstone Biologics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1B8
CA
Party NameTurnstone Biologics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1B8
CA
Party NameTurnstone Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1B8
CA

Trademark Events

Event DateEvent Description
Thursday, November 20, 2014NEW APPLICATION ENTERED
Monday, November 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 25, 2014NOTICE OF PSEUDO MARK E-MAILED
Saturday, March 7, 2015ASSIGNED TO EXAMINER
Saturday, March 14, 2015NON-FINAL ACTION WRITTEN
Saturday, March 14, 2015NON-FINAL ACTION E-MAILED
Saturday, March 14, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 28, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 30, 2015ASSIGNED TO LIE
Thursday, April 30, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 1, 2015SUSPENSION LETTER WRITTEN
Friday, May 1, 2015LETTER OF SUSPENSION E-MAILED
Friday, May 1, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 2, 2015ASSIGNED TO LIE
Monday, November 2, 2015SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, November 23, 2015SUSPENSION INQUIRY WRITTEN
Monday, November 23, 2015INQUIRY TO SUSPENSION E-MAILED
Monday, November 23, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, May 9, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 19, 2016ASSIGNED TO LIE
Thursday, May 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 11, 2016SUSPENSION LETTER WRITTEN
Saturday, June 11, 2016LETTER OF SUSPENSION E-MAILED
Saturday, June 11, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 15, 2016SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, January 5, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, June 5, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, June 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 8, 2017SUSPENSION LETTER WRITTEN
Thursday, June 8, 2017LETTER OF SUSPENSION E-MAILED
Thursday, June 8, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 12, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, December 22, 2017SUSPENSION INQUIRY WRITTEN
Friday, December 22, 2017INQUIRY TO SUSPENSION E-MAILED
Friday, December 22, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 17, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, January 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 22, 2018SUSPENSION LETTER WRITTEN
Monday, January 22, 2018LETTER OF SUSPENSION E-MAILED
Monday, January 22, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 2, 2018ASSIGNED TO LIE
Thursday, August 2, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 14, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 6, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 6, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2019ASSIGNED TO LIE
Wednesday, August 28, 2019SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, September 12, 2019SUSPENSION INQUIRY WRITTEN
Thursday, September 12, 2019INQUIRY TO SUSPENSION E-MAILED
Thursday, September 12, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, December 19, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 21, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 21, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 31, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, July 31, 2020EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020EXAMINER'S AMENDMENT ENTERED
Friday, July 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020REGISTERED-PRINCIPAL REGISTER
Monday, November 24, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

tbio cancer viral infectious oncolytic products treatment field diseases vaccines pharmaceutical